840 MEMORIAL DRIVE, CAMBRIDGE, MA
Mersana Therapeutics Enters Merger Agreement with Day One Biopharmaceuticals
Provides Business Update and Announces Third Quarter 2025 Financial Results
To Acquire Therapeutics
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Provides Business Update and Announces Second Quarter 2025 Financial Results
News, Articles of Incorporation
End of Material Contract
Shareholder votes
Q3
Q2
Q1
FY 2024
FY 2023
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
S-8 POS
Post-Effective Amendment to Registration Statement
Amended Tender Offer Statement by Third Party
Amended Schedule 14D-9 Solicitation/Recommendation Statement